Clinical Trials for ProQR Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ProQR Therapeutics

Clinical Trials (2)

NCT04123626
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Oct 7, 2019 · Completed: Jun 7, 2022
8 conditions1 sponsor5 locations
NCT03913143
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
PHASE2/PHASE3Active, not recruiting
36 participants
Started: Apr 4, 2019 · Completed: Mar 31, 2023
10 conditions1 sponsor14 locations